SCHEMBL1998115

SCHEMBL1998115

O=C1CN(Cc2ccc(-c3cccc(CN4CCS(=O)(=O)CC4)c3)cc2)C(=O)N1CC1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
DHODH Q02127 1/20 0.41
ENPP2 Q13822 1/20 0.39
FAAH O00519 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
JAK1 P23458 4/20 0.38
JAK2 O60674 2/20 0.38
TYK2 P29597 2/20 0.38
CYP2C19 P33261 2/20 0.38
STK10 O94804 1/20 0.38
ABL1 P00519 1/20 0.38
CYP1A2 P05177 1/20 0.38
CSF1R P07333 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
FLT3 P36888 1/20 0.38
STAT1 P42224 1/20 0.38
IRAK1 P51617 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1998174 0.86 CYP2D6 (0.48) ENPP2CYP2C19HRH3MCHR1CYP2D6
SCHEMBL1998874 0.85 MCHR1 (0.35) ENPP2MEN1KMT2AJAK1JAK2
SCHEMBL2002675 0.85 DHODH (0.43) LMNADHODHENPP2FAAHMEN1
SCHEMBL1999482 0.84 ENPP2 (0.48) LMNADHODHENPP2FAAHMEN1
SCHEMBL2000525 0.83 ENPP2 (0.52) LMNADHODHENPP2FAAHMEN1
SCHEMBL1998338 0.82 MCHR1 (0.40) ENPP2JAK1JAK2TYK2CYP2C19
SCHEMBL2002104 0.75 ENPP2 (0.43) ENPP2HDAC6CYP2D6
SCHEMBL1998795 0.73 CYP2D6 (0.49) ENPP2CYP2C19HRH3MCHR1HDAC6
SCHEMBL1997569 0.73 CYP2D6 (0.49) ENPP2CYP2C19HRH3MCHR1HDAC6
SCHEMBL1998864 0.71 HRH3 (0.43) DHODHENPP2CYP2C19HRH3MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US claimed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US claimed
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 LMNA 4840/4885DHODH 1578/4885ENPP2 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.